Unknown

Dataset Information

0

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells.


ABSTRACT: RAS mutations occur frequently in human cancer and activated RAS signalling contributes to tumour development and progression. Apart from its oncogenic effects on cell growth, active RAS has tumour-suppressive functions via its ability to induce cellular senescence and apoptosis. RAS is known to induce p53-dependent cell cycle arrest, yet its effect on p53-dependent apoptosis remains unclear. We report here that apoptosis-stimulating protein of p53 (ASPP) 1 and 2, two activators of p53, preferentially bind active RAS via their N-terminal RAS-association domains (RAD). Additionally, ASPP2 colocalises with and contributes to RAS cellular membrane localisation and potentiates RAS signalling. In cancer cells, ASPP1 and ASPP2 cooperate with oncogenic RAS to enhance the transcription and apoptotic function of p53. Thus, loss of ASPP1 and ASPP2 in human cancer cells may contribute to the full transforming property of RAS oncogene.

PROVIDER: S-EPMC3595493 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC2532732 | BioStudies
2004-01-01 | S-EPMC321425 | BioStudies
| S-EPMC3847091 | BioStudies
| S-EPMC7142079 | BioStudies
| S-EPMC2679482 | BioStudies
| S-EPMC4747173 | BioStudies
| S-EPMC3917971 | BioStudies
| S-EPMC3538245 | BioStudies
2011-01-01 | S-EPMC3131893 | BioStudies
| S-EPMC4954646 | BioStudies